Pulnovo Medical, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure, has recently announced that Ms.Lynne Wu officially joined and served as the Chief Financial Officer in March 2024, fully responsible for the company's financial management and capital market work, helping Pulnovo Medical enter a new stage of development and jointly open a new chapter for the company!

Ms.Lynne Wu has 15 years of experience in financial management, capital markets and risk control. Prior to joining Pulnovo Medical in the first quarter of 2024, she served as a sponsor and executive Director of Morgan Stanley's Healthcare team, where she was responsible for leading and successfully completing a number of major capital markets transactions. Previously, she held various management positions in leading international companies such as McKinsey, Jefferies and HSBC, demonstrating her outstanding competence and deep knowledge in her professional field. She has strong leadership and strategic vision in financing, IPOs in the US and Hong Kong, and corporate governance. She has successfully led and completed more than 20 IPOs and over 50 capital market and cross-border M&A transactions (including cross-border M&A, bond issuance and subsequent equity issuance), achieving leapfrog development for many enterprises. Her professional ability and rich experience will bring more accurate and efficient financial management and capital operation to Pulnovo Medical. Ms.Lynne Wu studied at Tsinghua University and she holds degrees in Economics and finance from the University of Hong Kong and the University of California, Irvine.

Cynthia Chen,Pulnovo Medical's Chairlady said:"As one of the key pillars of the company, the CFO plays a key role in ensuring that the company operates robustly and efficiently in a capital environment. In the current changing market environment, various challenges and opportunities coexist. With the continuous expansion of the scale of Pulnovo Medical and the development of the company's global commercial business, We believe that with Ms.Lynne Wu's rich experience in the fields of capital market, merger and acquisition transactions and financial management, she can use keen business insight and forward-looking thinking to make evaluation judgment and decision support for the company in investment, financing and M&A, cope with challenges and seize opportunities, and promote Pulnovo Medical to continue to lead in the field of medical health technology and move towards a broader development path. Pulnovo Medical would like to extend a warm welcome and sincere congratulations to Ms.Lynne Wu!"

Ms.Lynne Wu said:"It is an honour to join and serve as Chief Financial Officer of Pulnovo Medical during this period of rapid growth, which is not only a great responsibility, but also an exciting new starting point. Pulnovo Medical plays a leading role in the industry, not only driving the advancement of medical technology, but also striving to improve the health and quality of life of patients worldwide. I deeply admire its commitment to innovation and social responsibility. I look forward to using my professional knowledge and experience to provide strong support for the company's financial management and capital operations. I will strive to promote the company's strategic deployment in investment, financing and mergers and acquisitions, and inject new vitality into the company's development. In the future, I will join hands with Pulnovo Medical and provide financial support and capital operation for the exploration of breakthrough technologies and the global commercialization of the company, bringing new therapeutic hope and gospel to more patients."

About Pulnovo Medical

Pulnovo Medical Limited, is a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure. Established in 2013 and rooted in innovation, Pulnovo Medical is committed to leveraging our deep expertise in the science of breakthrough technology with the goal to market our innovative therapeutic solutions and benefit patients around the world.

For more information, please visit: www.pulnovomed.us